Covered recipient · General Payments record
JAMIE T VU
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$3,138.32
- Reported across 172 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $360.02 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $197.01 | 11 |
| Supernus Pharmaceuticals, Inc. | $40.06 | 1 |
| Novo Nordisk AS | $39.90 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $24.79 | 1 |
| Nevro Corp. | $22.64 | 1 |
| Kowa Pharmaceuticals America, Inc. | $18.29 | 1 |
| Lilly USA, LLC | $17.33 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $29.42 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108366282 | CMS |
| ABBVIE INC. | $26.50 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108366284 | CMS |
| ABBVIE INC. | $3.93 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108366286 | CMS |
| ABBVIE INC. | $20.78 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108366288 | CMS |
| ABBVIE INC. | $30.74 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108366290 | CMS |
| ABBVIE INC. | $15.98 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108366292 | CMS |
| ABBVIE INC. | $17.09 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108366294 | CMS |
| ABBVIE INC. | $7.72 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108366296 | CMS |
| ABBVIE INC. | $21.22 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108366298 | CMS |
| ABBVIE INC. | $16.04 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108366300 | CMS |
| ABBVIE INC. | $7.59 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108366302 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $24.79 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086301946 | CMS |
| Kowa Pharmaceuticals America, Inc. | $18.29 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113475125 | CMS |
| Lilly USA, LLC | $17.33 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135673796 | CMS |
| Nevro Corp. | $22.64 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130767495 | CMS |
| Novo Nordisk Inc | $19.70 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100649187 | CMS |
| Novo Nordisk Inc | $20.20 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100525585 | CMS |
| Supernus Pharmaceuticals, Inc. | $40.06 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147894893 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.